S-100 protein and neuron-specific enolase concentrations in blood as indicators of infarction volume and prognosis in acute ischemic stroke

Stroke

Volumn 28, Issue 10, 1997, Pages 1956-1960

  Missler, Ulrich ^a   Wiesmann, Martin ^a   Friedrich, Christine ^a   Kaps, Manfred ^b  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF LÜBECK   (Germany)

Author keywords

Blood proteins; Cerebral infarction; Computed tomography; Neuron specific enolase; Prognosis

Indexed keywords

ENOLASE; PROTEIN S 100;

ADULT; AGED; ARTICLE; BLOOD LEVEL; BRAIN INFARCTION; CELL SPECIFICITY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC VALUE; DISEASE SEVERITY; ENZYME SPECIFICITY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; STROKE;

EID: 0030711721     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.28.10.1956     Document Type: Article

References (24)

1. Aurell A, Rosengren LE, Karlsson B, Olsson JE, Zbornikova V, Haglid KG. Determination of S-100 and glial fibrillary acidic protein concentrations in cerebrospinal fluid after brain infarction. Stroke. 1991;22:1254-1258.
2. Barone FC, Clark RK, Price WJ, White RF, Feuerstein GZ, Storer BL, Ohlstein EH. Neuron-specific enolase increases in cerebral and systemic circulation following focal ischemia. Brain Res. 1993;623:77-82.
3. Cunningham RT, Young IS, Winder J, O'Kane MJ, McKinstry S, Johnston CF, Dolan OM, Hawkins SA, Buchanan KD. Serum neurone specific enolase (NSE) levels as an indicator of neuronal damage in patients with cerebral infarction. Eur J Clin Invest. 1991;21:497-500.
4. Hårdemark HG, Ericsson N, Kotwica Z, Rundström G, Mendel-Hartvig I, Olsson Y, Påhlman S, Persson L. S-100 protein and neuron-specific enolase in CSF after experimental traumatic or focal ischemic brain damage. J Neurosurg. 1989;71:727-731.
5. Hårdemark HG, Persson L, Bolander HG, Hillered L, Olsson Y, Påhlman S. Neuron-specific enolase is a marker of cerebral ischemia and infarct size in rat cerebrospinal fluid. Stroke. 1988;19:1140-1144.
6. Hatfield RH, McKernan RM. CSF neuron-specific enolase as a quantitative marker of neuronal damage in a rat stroke model. Brain Res. 1992;577:249-252.
7. Hay E, Royds JA, Davies-Jones GAB, Lewtas NA, Timperley WR, Taylor CB. Cerebrospinal fluid enolase in stroke. J Neurol Neurosurg Psychiatry. 1984;47:724-729.
8. Kawasaki H, Wakayama Y, Okayasu H, Takahashi H, Shibuya S. Levels of serum and cerebrospinal fluid enolase in patients with cerebral vascular disease and other neurological diseases. Stroke. 1988;19:313-318.
9. Noppe M, Crols R, Andries D, Lowenthal A. Determination in human cerebrospinal fluid of glial fibrillary acidic protein, S-100 and myelin basic protein as indices of non-specific or specific central nervous tissue pathology. Clin Chim Acta. 1986;155:143-150.
10. Steinberg R, Gueniau C, Scarna H, Keller A, Worcel M, Pujol JF. Experimental brain ischemia: neuron-specific enolase level in cerebrospinal fluid as an index of neuronal damage. J Neurochem. 1984;43:19-24.
11. Missler U, Wiesmann M. Measurement of S-100 protein in human blood and cerebrospinal fluid: analytical method and preliminary clinical results. Eur J Clin Chem Clin Biochem. 1995;33:743-748.
12. Millikan CH. A classification and outline of cerebrovascular disease. Stroke. 1975;6:565-616.
13. Jennett B, Bond M. Assessment of outcome after severe brain damage. Lancet. 1975;1:480-484.
14. Baudier J, Glasser N, Gérard D. Ions binding to S100 proteins. J Biol Chem. 1986;261:8192-8203.
15. Donato R. Perspectives in S-100 protein biology. Cell Calcium. 1991;12:713-726.
16. Fanó G, Biocca S, Fulle S, Mariggió MA, Belia S, Calissano P. The S100: A protein family in search of a function. Prog Neurobiol. 1995;46:71-82.
17. Marangos PJ, Schmechel DE. Neuron-specific enolase, a clinically useful marker for neurons and neuroendocrine cells. Ann Rev Neurosci. 1987;10:269-295.
18. Massaro AR, Scivoletto G, Tonali P. Cerebrospinal fluid markers in neurological disorders. Ital J Neurol Sci. 1990;11:537-547.
19. Cunningham RT, Watt M, Winder J, McKinstry S, Lawson JT, Johnston CF, Hawkins SA, Buchanan KD. Serum neurone-specific enolase as an indicator of stroke volume. Eur J Clin Invest. 1996;26:298-303.
20. Schaarschmidt H, Prange HW, Reiber HO. Neuron-specific enolase concentrations in blood as a prognostic parameter in cerebrovascular diseases. Stroke. 1994;25:558-565.
21. Persson L, Hårdemark HG, Gustafsson J, Rundström G, Mendel-Hartvig I, Esscher T, Påhlman S. S-100 protein and neuron-specific enolase in cerebrospinal fluid and serum: markers of cell damage in human central nervous system. Stroke. 1987;18:911-918.
22. Butterworth RJ, Wassif WS, Sherwood RA, Gerges A, Poyser KH, Garthwaite J, Peters TJ, Bath PMW. Serum neuron-specific enolase, carnosinase, and their ratio in acute stroke: an enzymatic test for predicting outcome? Stroke. 1996;27:2064-2068.
23. Kim JS, Yoon SS, Kim YH, Ryu JS. Serial measurement of interleukin-6, transforming growth factor-β, and S-100 protein in patients with acute stroke. Stroke. 1996;27:1553-1557.
24. Ishiguro Y, Kato K, Ito T, Nagaya M, Yamada N, Sugito T. Nervous system-specific enolase in serum as a marker for neuroblastoma. Pediatrics. 1983;72:696-700.